Antigen-based rapid diagnostic testing or alternatives for diagnosis of symptomatic COVID-19: a simulation-based net benefit analysis
<p><strong>Background:</strong> SARS-CoV-2 antigen-detection rapid diagnostic tests can diagnose COVID-19 rapidly and at low cost, but lower sensitivity compared with reverse-transcriptase polymerase chain reaction (PCR) has limited clinical adoption.</p> <p><strong...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Lippincott, Williams and Wilkins
2021
|